Clinical trials: Movement Abnormalities
Parkinson Disease
A Phase 1b Study of the NLRP3 Inhibitor VENT-02 in Patients With Mild to Moderate Parkinson's Disease
This trial is a randomized, double-blind, placebo-controlled Phase 1b study evaluating the safety/tolerability, PK, and pharmacodynamics of VENT 02, administered orally at 1 dose level twice daily (BID) over 28 days in patients…
- Trial name
- NCT06822517
- Testing
- VENT-02
- Where
- 23 sites in United States
- Volunteers
- 29 people
- Sponsor
- Ventus Therapeutics U.S., Inc.
Lewy Body Disease
Longitudinal Imaging Biomarkers of Disease Progression in DLB
The Researchers are trying to determine the paths of change in imaging biomarkers of Dementia with Lewy bodies (DLB) and their associations with rate of cognitive and functional decline.
- Trial name
- NCT03582488
- Testing
- 18F-Flortaucipir
- Where
- 2 sites in United States
- Volunteers
- 135 people
- Sponsor
- Kejal Kantarci
Falls, Balance
Postural Effects of Being Rotated in a Whole Body Gyroscope
Subjects will be secured and rotated in a whole body gyroscope, similar to a flight trainer for astronauts. The rotations will be in many directions and the speed will be at 90 deg/sec.
- Conditions
- Falls, Balance, Movement Disorders
- Trial name
- Gyro (NCT01188161)
- Testing
- Rotating Chair
- Where
- United States
- Volunteers
- 25 people, healthy volunteers welcome
- Sponsor
- Carrick Institute for Graduate Studies
Parkinson Disease
Cost of Parkinson's Disease in Hong Kong
The goal of this study is to estimate the cost of disease and falls among people with Parkinson's disease in Hong Kong . There will be no intervention delivered to the participants.
- Trial name
- Burden of PD (NCT05774210)
- Volunteers
- 139 people
- Sponsor
- The Hong Kong Polytechnic University
Parkinson's Disease, Isolated Dystonia
Chronic Effects of DBS in Parkinson's Disease and Dystonia
The purpose of this study is to use an investigational device to record brain activity for 12-24 months following surgical implantation of deep brain stimulation (DBS) systems.
- Trial name
- Activa PC+S (NCT01934296)
- Testing
- Activa PC+S
- Where
- United States
- Volunteers
- 9 people
- Sponsor
- University of California, San Francisco
Parkinson Disease, Respiration
Telerehabilitation Based Exercise Training in Parkinson's Patients
Parkinson's disease (PD) is the second most common progressive disease after Alzheimer's disease.It is a progressive, multisystemic and neurodegenerative disease. The prevalence of Parkinson's disease increases with age.
- Conditions
- Parkinson Disease, Respiration, Gait Disorders, Neurologic
- Trial name
- NCT05621642
- Testing
- Breathing exercises, Core stabilization exercises, Balance and strengthening exercises
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Istanbul University - Cerrahpasa
Lewy Body Dementia, Parkinson Disease
Anti-Diabetic Medications to Fight PD and LBD
The purpose of this study is to test the hypothesis that DPP4 inhibitors and SGLT2 inhibitors are well tolerated and have beneficial neurological effects, specifically for Parkinson's disease and Lewy body dementia.
- Trial name
- NCT06263673
- Testing
- Sitagliptin, Dapagliflozin
- Where
- United States
- Volunteers
- 18 people
- Sponsor
- Mayo Clinic
Parkinson Disease
AV133 Longitudinal Imaging Study in Patients With Early and Prdromal Parkinson's Disease
A total of 38 patients with early-stage Parkinson's disease and 38 patients with prodromal Parkinson's disease are planned to be enrolled in this study and examined for longitudinal changes in [18F]AV-133 through follow-up…
- Trial name
- NCT06456684
- Testing
- Fluoro[18F]promethazine
- Where
- China
- Volunteers
- 76 people
- Sponsor
- Xuanwu Hospital, Beijing
Pure Autonomic Failure, Multiple System Atrophy
Magnetic Resonance Spectroscopy in Autonomic Failure
This research study will be conducted in patients with primary autonomic failure, a disabling condition that is associated with low blood pressure upon standing.
- Trial name
- NCT01607268
- Testing
- Magnetic Resonance Spectroscopy Imaging
- Where
- United States
- Volunteers
- 6 people
- Sponsor
- Vanderbilt University
Young Onset Parkinson Disease, Parkinson Disease
Young Onset Parkinson's Disease Subtypes and Pathogenic Mechanisms
Young Onset Parkinson's disease (YOPD) refers to a group of patients in which the disease starts earlier in life (before the age of 50 years) and has a profound impact on most of patient's life.
- Trial name
- YOPD (NCT07752355)
- Where
- United States
- Volunteers
- 250 people, healthy volunteers welcome
- Sponsor
- NYU Langone Health
Parkinson Disease 6, Early-Onset, Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human
Hereditary Parkinson s Disease Natural History Protocol
Background: Parkinson s disease is a disease of the nervous system that affects movement. People usually get it in their 70s or 80s. Early onset Parkinson s disease (EOPD) begins before the age of 50.
- Conditions
- Parkinson Disease 6, Early-Onset, Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human, Parkinson Disease Autosomal Recessive, Early Onset, Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1
- Trial name
- NCT02511015
- Where
- United States
- Volunteers
- 31 people
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
Parkinson Disease
Deep Brain Stimulation Neural Recordings of Varied Stimulation During Sleep in Parkinson's Disease
This study employs an exploratory, prospective, single center, naturalistic clinical trial design with a randomized crossover intervention.
- Trial name
- DREAMS-PD (NCT07110376)
- Testing
- Nighttime Deep Brain Stimulation with Varying Amplitude Settings
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- The Cleveland Clinic
Parkinson Disease, Orthostatic Hypotension
Cardiovascular Effects of Exercise in Patients With Parkinson's Disease
Abnormalities in the regulation of cardiovascular system due to autonomic nervous system (ANS) dysfunction may lead to a sudden decline in blood pressure (BP) upon standing, sitting or performing activities/exercises in patients…
- Trial name
- NCT03343574
- Testing
- Abdominal Strengthening Exercise
- Where
- Canada
- Volunteers
- 300 people
- Sponsor
- Faizan Ahmed
Dentatorubral-Pallidoluysian Atrophy
Dentatorubral-pallidoluysian Atrophy Natural History and Biomarkers Study
DRPLA Natural History and Biomarkers Study (DRPLA NHBS) is a prospective observational study that will lay the foundation for clinical trials in DRPLA.
- Trial name
- DRPLA NHBS (NCT06273150)
- Testing
- Positive genetic test for pathological expansion in ATN1
- Where
- 3 sites in United States, United Kingdom
- Volunteers
- 225 people, healthy volunteers welcome
- Sponsor
- University College, London
Idiopathic Parkinson's Disease (PD)
Association of VAgus Nerve Stimulation and Treadmill Training for GAit Rehabilitation in DE Novo Parkinson's Disease
The goal of this clinical trial is to learn if transcutaneous auricular vagus nerve stimulation (taVNS) can improve gait and brain function in people with diagnosis of idiopathic Parkinson's disease (PD) within 6 months.
- Trial name
- AVANTGARDE-PD (NCT07337226)
- Testing
- Transcutaneous Auricular Vagus Nerve Stimulation (taVNS), Conventional Physical Therapy (cPT), Sensorized Treadmill Training (STT)
- Where
- Italy
- Volunteers
- 60 people
- Sponsor
- Fondazione Policlinico Universitario Campus Bio-Medico
Parkinson's Disease With Freezing of Gait
Validation of cueStim for Reduction of Freezing of Gait in Parkinson's Disease
The goal of this clinical trial is to learn if the cueStim device can reduce the duration of freezing of gait (FoG) that occurs in patients with Parkinson's Disease.
- Trial name
- NCT07675408
- Testing
- CueStim
- Where
- 6 sites in United States
- Volunteers
- 60 people
- Sponsor
- Fortis Medical Devices Limited
Parkinson Disease, Dyspepsia
Effect of Short-term Motilitone Therapy on Health-related Quality of Life in PD Patients With Gastrointestinal Symptoms
The purpose of this study is to determine whether DA-9701(Motilitone) is effective and safe for the treatment on health-related quality of life in Parkinson's disease (PD) patients with gastrointestinal symptoms.
- Trial name
- PASS-GI (NCT02775591)
- Testing
- DA-9701
- Where
- 5 sites in South Korea
- Volunteers
- 147 people
- Sponsor
- Seoul National University Hospital
Dystonia Disorder, Parkinson Disease
Botulinum Toxin Type A for Foot Dystonia-associated Pain in Parkinson's Disease
To study the effects of Botulinum toxin type A (BTXA) in the treatment of foot dystonia-associated pain in Parkinson's disease
- Trial name
- NCT04277247
- Testing
- Botulinum toxin type A
- Where
- Canada
- Volunteers
- 40 people
- Sponsor
- University of Calgary
Dyskinesias, Movement Disorders
Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia
A Multi-Center, Phase II, Randomized, Double-Blind, Prospective, Active Placebo-Controlled Trial of Sub-Anesthetic Intravenous Infusion of Ketamine to Treat Levodopa-Induced Dyskinesia in Subjects with Parkinson's Disease.
- Conditions
- Dyskinesias, Movement Disorders, Central Nervous System Diseases, Nervous System Diseases
- Trial name
- NCT04912115
- Testing
- Ketamine, Midazolam
- Where
- 7 sites in United States
- Volunteers
- 30 people
- Sponsor
- PharmaTher Inc.
Idiopathic Parkinson's Disease
Safety and Efficacy of CERE-120 in Subjects With Parkinson's Disease
The purpose of this study was to evaluate the safety and potential benefits of CERE-120 in the treatment of Parkinson's disease.
- Trial name
- NCT00985517
- Testing
- CERE-120: Adeno-Associated Virus Delivery of Neurturin
- Where
- 11 sites in United States
- Volunteers
- 57 people
- Sponsor
- Sangamo Therapeutics
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.